EEF1E1 and astrocytoma (excluding glioblastoma): AIMP1-cg24015814 and AIMP3-cg20512532 were also associated with improved DFS with bevacizumab treatment in astrocytoma at multivariate analysis (Fig. 5) and may thus be of particular importance in gliomas in general, warranting further investigations which is beyond the scope of this study.